Neurology News

Artificial intelligence has offered exciting new innovations for clinicians, but the next step may be AI communicating like clinicians, too.

President Joe Biden plans to nominate NCI Director Monica M. Bertagnolli, MD, FACS, FASCO, to serve as director of the NIH, according to published reports.

The FDA has approved Prospera, a spinal cord stimulation system to treat those with chronic intractable pain in the upper body and limbs.

The FDA has granted clearance to Neuspera Medical for its novel implantable system to treat chronic peripheral nerve pain.

Healio’s top stories on Parkinson’s disease in the first portion of 2023 include an FDA inquiry into a treatment pump, adjunctive therapy for carbidopa/levodopa and results from several clinical trials. Here’s what you may have missed:

Statin therapy may improve risk for stroke or transient ischemic attack among patients with atrial fibrillation compared with nonuse, regardless of concomitant anticoagulant use, a speaker reported.

Most physicians who work together with other physician colleagues — as co-owners, employees and/or independent contractors — in the same organization consider themselves as part of a physician practice.

The FDA has approved expanding the indication of Qulipta, an oral calcitonin gene-related peptide receptor antagonist, for preventing migraine in adults.

Two FDA advisory committees voted in favor of a supplemental new drug application for Rexulti, ruling there was sufficient data to show treatment for agitation associated with Alzheimer’s dementia outweighed the risks.

Adults with atrial fibrillation and vascular dementia have a higher risk for stroke, rehospitalization and mortality compared with those with AF and Alzheimer’s disease, who have a higher risk for intercranial hemorrhage, data show.